Insulin makers testify on Capitol Hill over prices
By Ahmed Aboulenein WASHINGTON (Reuters) – Leaders of major insulin makers and pharmacy benefit managers (PBMs) traded blame for the life-saving drug’s high price on Wednesday while testifying at a U.S. Senate committee hearing on making it more affordable. PBMs negotiate with drugmakers for rebates and lower fees on behalf of employers and other clients, and reimburse pharmacies for prescriptions they dispense. Both sides blame each other for high drug […]